Free Trial

Keybank National Association OH Sells 8,478 Shares of CME Group Inc. (NASDAQ:CME)

CME Group logo with Finance background

Keybank National Association OH decreased its holdings in shares of CME Group Inc. (NASDAQ:CME - Free Report) by 5.8% in the first quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 137,092 shares of the financial services provider's stock after selling 8,478 shares during the period. Keybank National Association OH's holdings in CME Group were worth $36,369,000 as of its most recent SEC filing.

Other institutional investors also recently modified their holdings of the company. Vanguard Group Inc. boosted its holdings in shares of CME Group by 1.0% in the 4th quarter. Vanguard Group Inc. now owns 34,243,090 shares of the financial services provider's stock valued at $7,952,273,000 after buying an additional 326,623 shares during the last quarter. Geode Capital Management LLC boosted its holdings in shares of CME Group by 1.3% in the 4th quarter. Geode Capital Management LLC now owns 8,389,442 shares of the financial services provider's stock valued at $1,946,717,000 after purchasing an additional 104,697 shares in the last quarter. Price T Rowe Associates Inc. MD lifted its stake in CME Group by 89.9% in the 4th quarter. Price T Rowe Associates Inc. MD now owns 8,280,785 shares of the financial services provider's stock valued at $1,923,047,000 after purchasing an additional 3,921,278 shares during the last quarter. Norges Bank bought a new stake in shares of CME Group during the fourth quarter worth about $1,107,389,000. Finally, FIL Ltd lifted its holdings in CME Group by 1.5% during the 4th quarter. FIL Ltd now owns 4,081,391 shares of the financial services provider's stock worth $947,821,000 after buying an additional 61,908 shares during the period. Institutional investors own 87.75% of the company's stock.

Insiders Place Their Bets

In other CME Group news, Director Dennis Suskind sold 1,000 shares of the business's stock in a transaction on Tuesday, April 29th. The shares were sold at an average price of $271.28, for a total transaction of $271,280.00. Following the completion of the transaction, the director owned 2,915 shares of the company's stock, valued at $790,781.20. The trade was a 25.54% decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. Also, insider Derek Sammann sold 4,650 shares of the company's stock in a transaction dated Monday, May 5th. The stock was sold at an average price of $280.61, for a total transaction of $1,304,836.50. Following the transaction, the insider owned 8,336 shares in the company, valued at approximately $2,339,164.96. This trade represents a 35.81% decrease in their position. The disclosure for this sale can be found here. Insiders sold a total of 13,400 shares of company stock valued at $3,680,610 in the last three months. Company insiders own 0.30% of the company's stock.

Wall Street Analysts Forecast Growth

CME has been the topic of several recent research reports. Citigroup increased their price target on CME Group from $265.00 to $275.00 and gave the stock a "neutral" rating in a report on Thursday. Oppenheimer lifted their price objective on CME Group from $282.00 to $300.00 and gave the company an "outperform" rating in a research note on Wednesday, June 4th. Morgan Stanley upped their target price on CME Group from $301.00 to $304.00 and gave the stock an "overweight" rating in a research note on Thursday, April 24th. UBS Group increased their price target on shares of CME Group from $290.00 to $305.00 and gave the company a "buy" rating in a research report on Friday, April 25th. Finally, Barclays lifted their price objective on CME Group from $279.00 to $283.00 and gave the company an "equal weight" rating in a research report on Wednesday, April 23rd. Three investment analysts have rated the stock with a sell rating, eight have assigned a hold rating and five have issued a buy rating to the company's stock. According to data from MarketBeat.com, the company currently has a consensus rating of "Hold" and an average price target of $259.87.

Get Our Latest Analysis on CME

CME Group Trading Down 0.4%

Shares of CME stock traded down $1.00 during trading hours on Thursday, hitting $274.83. 1,234,017 shares of the company were exchanged, compared to its average volume of 2,194,580. CME Group Inc. has a 1 year low of $193.17 and a 1 year high of $290.79. The firm has a fifty day moving average of $276.00 and a 200 day moving average of $257.35. The company has a quick ratio of 1.02, a current ratio of 1.02 and a debt-to-equity ratio of 0.13. The firm has a market cap of $99.04 billion, a PE ratio of 27.65, a PEG ratio of 3.74 and a beta of 0.44.

CME Group (NASDAQ:CME - Get Free Report) last posted its quarterly earnings results on Wednesday, April 23rd. The financial services provider reported $2.80 earnings per share (EPS) for the quarter, beating the consensus estimate of $2.61 by $0.19. The business had revenue of $1.64 billion for the quarter, compared to analyst estimates of $1.56 billion. CME Group had a return on equity of 14.03% and a net margin of 57.71%. The business's revenue was up 10.4% compared to the same quarter last year. During the same period in the prior year, the company posted $2.50 EPS. Analysts expect that CME Group Inc. will post 10.49 earnings per share for the current year.

CME Group Announces Dividend

The firm also recently announced a quarterly dividend, which was paid on Wednesday, June 25th. Shareholders of record on Monday, June 9th were paid a dividend of $1.25 per share. The ex-dividend date of this dividend was Monday, June 9th. This represents a $5.00 annualized dividend and a yield of 1.82%. CME Group's dividend payout ratio (DPR) is presently 50.30%.

CME Group Company Profile

(Free Report)

CME Group Inc, together with its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers futures and options products based on interest rates, equity indexes, foreign exchange, agricultural commodities, energy, and metals, as well as fixed income and foreign currency trading services.

See Also

Institutional Ownership by Quarter for CME Group (NASDAQ:CME)

Should You Invest $1,000 in CME Group Right Now?

Before you consider CME Group, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and CME Group wasn't on the list.

While CME Group currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

Reduce the Risk Cover

Market downturns give many investors pause, and for good reason. Wondering how to offset this risk? Enter your email address to learn more about using beta to protect your portfolio.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

3 Cheap Growth Stocks Set to Explode This Summer
The Next NVIDIA? Quantum Computing Stocks Set for Explosive Growth
5 Stocks to BUY NOW in July 2025

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines